Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Centene (CNC) Could Beat Earnings Estimates Again

ST. LOUIS , Oct. 5, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2022 third quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, October 25, 2022, and will host a conference call afterwards at approximately 8:30 a.m.

CENTENE CORPORATION SCHEDULES 2022 THIRD QUARTER FINANCIAL RESULTS CONFERENCE CALL

Wellcare Medicare Advantage plans available in 209 new counties Wellcare will offer a total of 102 Prescription Drug Plans nationwide Value Based Insurance Design (VBID) model to improve health outcomes and lower costs for members with low-income subsidy on all Dual Eligible Special Needs Plans (D-SNPs) Amazon added to preferred retail pharmacy network† TAMPA, Fla. , Oct. 3, 2022 /PRNewswire/ -- Wellcare, a wholly owned subsidiary of Centene Corporation (NYSE: CNC), announced today it will expand its wide range of Medicare Advantage (MA) and Medicare Prescription Drug Plan (PDP) offerings during the 2023 Medicare Annual Enrollment Period (AEP) beginning Oct. 15, 2022.

Wellcare Expands Medicare Advantage and Medicare Prescription Drug Plan Offerings for 2023

Centene (CNC) rides on continued top-line growth and numerous contract wins. Divestitures and an adequate cash-generating ability equip CNC well to invest in growth-related initiatives.

Factors That Make Centene (CNC) an Attractive Bet for Investors

Health Net's Sophisticated Health Equity Model of Care for Medi-Cal, Marketplace, Medicare and Commercial Members Earns First-in-the-Nation Recognition for the Company SACRAMENTO,Calif., Sept. 29, 2022 /PRNewswire/ -- Health Net announced today that it is one of nine healthcare organizations in the nation to receive the first-ever Health Equity Accreditation Plus by the National Committee for Quality Assurance (NCQA) for all lines of business including Medi-Cal, Marketplace, Medicare and Commercial.

Health Net Awarded "Health Equity Accreditation Plus" by Prestigious National Committee for Quality Assurance

The market has been in chaos, as you know. The stocks in the healthcare and insurance space have held up well.

Centene: A Chaos Stock

The Nebraska DHHS awards a contract to Centene's (CNC) Nebraska arm to continue serving the unmet need of the state's Medicaid members with a suite of better healthcare options.

Centene's (CNC) Contract Win to Aid Nebraska's Medicaid Members

Centene (CNC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Centene (CNC) Upgraded to Buy: Here's What You Should Know

Humana

Molina Healthcare

UnitedHealth Group

A growing customer base and numerous contract wins might drive the Medical-HMO industry. However, high expenses related to technology advancements and a shortage of nurses will dampen margins.

4 HMO Stocks to Watch Despite Escalating Technology Expenses

ST. LOUIS , Sept. 26, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its Nebraska subsidiary, Nebraska Total Care, has been awarded the Nebraska Department of Health and Human Services (DHHS) statewide Medicaid managed care contract.

Centene Subsidiary Selected to Continue Serving Nebraska's Medicaid Managed Care Members

Centene's (CNC) Texas subsidiary secures a contract to continue catering to the state's foster children and youth via its Medicaid plans.

Centene (CNC) Wins Contract to Serve Texas' Foster Population

ST. LOUIS , Sept. 15, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its Texas subsidiary, Superior HealthPlan (Superior), will continue to provide children and youth in foster care with healthcare coverage through the STAR Health Medicaid program.

Centene's Texas Subsidiary Announces Successful Reprocurement of Foster Care Contract

Elevance Health Inc

Managed health care stocks fall within the Medical-Managed Care group, which ranks a high No. 15 out of the 197 industries IBD tracks.

Managed Medical Care Stocks Group Moving Up The Ranks

ST. LOUIS , Sept. 6, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Morgan Stanley 20th Annual Global Healthcare Conference, to be held Monday, September 12 th – Wednesday, September 14 th in New York City.

Centene to Present at Morgan Stanley Global Healthcare Conference

ST. LOUIS , Sept. 1, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today the appointment of Ashlee Knuckey as Chief Ethics and Compliance Officer.

CENTENE CORPORATION APPOINTS ASHLEE KNUCKEY AS CHIEF ETHICS AND COMPLIANCE OFFICER

Centene (CNC) is likely to appeal the decision to avoid disruption in services and it has time until Sep 1, 2022, to do so.

Centene (CNC) Wins Medi-Cal Contracts but Loses 3 Counties

ST. LOUIS , Aug. 25, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) issued the following statement after the announcement of the award of the Medi-Cal Managed Care contracts: "As one of the state's longest serving and most experienced Medi-Cal partners, we are pleased to have been awarded contracts by the California Department of Health Care Services to continue serving members in nine counties across California." "However, we are disappointed to learn the state has chosen not to award us contracts in Los Angeles, Sacramento and Kern counties.

Centene Statement re: California's Medi-Cal Managed Care Contract Award

The health insurer's annual total returns have crushed the S&P 500 over the past 10 years.

Should You Buy This Market-Beating Blue Chip Stock?

Enphase Energy

First Solar

Invesco Solar ETF

T-Mobile US

During bull markets, it's not hard to find strong uptrend stocks. However, identifying such names during bear markets is a completely different story.

5 Strong Uptrend Stocks to Buy on the Next Dip

ST. LOUIS , Aug. 10, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its Mississippi subsidiary, Magnolia Health Plan (Magnolia), has been awarded the Mississippi Division of Medicaid (DOM) contract. Under the new contract, Magnolia will continue serving the state's Coordinated Care Organization Program, which will consist of the Mississippi Coordinated Access Network (MSCAN) and the Mississippi Children's Health Insurance Program (CHIP).

Centene Subsidiary Selected to Continue Serving Mississippi's Medicaid Managed Care Members

ST. LOUIS , Aug. 1, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission in connection with a special stockholders meeting to approve amendments to Centene's Amended and Restated Certificate of Incorporation to enhance the Company's corporate governance. The proposed amendments include immediately declassifying the Board so that the terms of all of the Company's current directors will end at the 2023 Annual Meeting of Stockholders and all director nominees will stand for election annually, removing the current prohibition on stockholders calling special meetings and, subject to certain terms and conditions, permitting stockholders to act by written consent.

CENTENE FILES PRELIMINARY PROXY STATEMENT FOR SPECIAL MEETING TO PROPOSE ENHANCED CORPORATE GOVERNANCE PROVISIONS

There are steps we can take to mitigate the volatility and benefit our portfolio as we move further into the second half of the year.

Stick With These Health Care Leaders in the Second Half of 2022

UnitedHealth and Centene are leading companies in managed care; UNH is a giant while CNC fills the niche of serving uninsured and under-insured. UnitedHealth has a picture perfect balance sheet and exceptionally consistent earnings growth along with low debt and low risk; its management is outstanding.

UnitedHealth Vs. Centene: Which Is The Better Buy?

Centene beat Q2 earnings views. Its outlook may be even brighter if there's a recession.

Recession-Proof? This S&P 500 Stock May Grow Faster In A Recession

Centene (CNC) currently has $3.4 billion remaining in its share buyback program.

News for Centene Stock (CNC)